Company Name | Total Employees |
---|---|
Walgreens Boots Alliance, Inc. | 206000 |
Rite Aid Corporation | 47000 |
High Tide Inc. | 1550 |
111, Inc. | 1520 |
China Jo-Jo Drugstores, Inc. | 939 |
BIMI International Medical Inc. | 296 |
PetMed Express, Inc. | 287 |
MedAvail Holdings, Inc. | 279 |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 217 |
LifeMD, Inc. | 207 |
Leafly Holdings, Inc. | 121 |
TRxADE HEALTH, Inc. | 8 |
Data in motion
The pharmaceutical industry has long been a cornerstone of global healthcare, driving innovation and providing essential medications. In 2023, the employment landscape within this sector reveals fascinating insights into the workforce distribution among leading companies.
At the forefront is Walgreens Boots Alliance, Inc., employing a staggering 206,000 individuals, which is more than four times the workforce of its closest competitor, Rite Aid Corporation, with 47,000 employees. This significant disparity highlights Walgreens' dominant position in the market.
Other notable companies include High Tide Inc. and 111, Inc., each with around 1,500 employees, showcasing their growing influence in the industry. Meanwhile, smaller firms like TRxADE HEALTH, Inc. operate with a lean team of just 8 employees, reflecting a diverse range of business models within the sector.
The data underscores the vast differences in company sizes and operational scales within the pharmaceutical industry. While some giants employ tens of thousands, others thrive with minimal staff, emphasizing the varied strategies and market niches that exist.
Understanding these employment trends provides valuable context for investors, job seekers, and industry analysts, offering a clearer picture of the human resources driving the pharmaceutical sector forward.
5 Year Trend in Average Market Capitalization for AbbVie
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
Average Market Capitalization of Abbvie Annually
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Pharma Companies
5 Year Trend in Average Market Capitalization for AbbVie
5 Year Trend in Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Number of Employees for Top 10 Healthcare Companies
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters